Targeted deep sequencing in untreated progressive CLL helps to better dissect the genomic landscape and shows novel associations between mutations, prognostic and clinical parameters: Data from E1912, a randomized phase III study of the ECOG-ACRIN cancer research group Meeting Abstract
| Authors: | Braggio, E.; Wang, V.; Bruins, L. A.; Barrio, S.; Lesnick, C.; Barrientos, J. C.; O'Brien, S. M.; Tallman, M. S.; Litzow, M. R.; Fonseca, R.; Kay, N. E.; Shanafelt, T. D. |
| Abstract Title: | Targeted deep sequencing in untreated progressive CLL helps to better dissect the genomic landscape and shows novel associations between mutations, prognostic and clinical parameters: Data from E1912, a randomized phase III study of the ECOG-ACRIN cancer research group |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419703298 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.4288.4288 |
| Notes: | Meeting Abstract: 4288 -- Source: Wos |
